Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody

Journal of Nuclear Medicine

Volumn 52, Issue 10, 2011, Pages 1601-1607

  Van Rij, Catharina M ^a   Sharkey, Robert M ^b   Goldenberg, David M ^b   Frielink, Cathelijne ^a   Molkenboer, Janneke D M ^a   Franssen, Gerben M ^a   Van Weerden, Wietske M ^c   Oyen, Wim J G ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

EGP 1; PET; Prostate cancer; Radioimmunoimaging; SPECT

Indexed keywords

EPITHELIAL GLYCOPROTEIN 1; INDIUM 111; IODINE 125; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HRS7; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ZIRCONIUM 89;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DOSE ESCALATION; HUMAN; HUMAN CELL; IMMUNO SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOPOSITRON EMISSION TOMOGRAPHY; ISOTOPE LABELING; MALE; MEDICAL ASSESSMENT; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; HUMANS; IMMUNOHISTOCHEMISTRY; INDIUM RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, HETEROLOGOUS; ZIRCONIUM;

EID: 80053501163     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.086520     Document Type: Article

References (19)

1. Zaheer A, Cho SY, Pomper MG. New agents and techniques for imaging prostate cancer. J Nucl Med. 2009;50:1387-1390.
2. Beheshti M, Langsteger W, Fogelman I. Prostate cancer: role of SPECT and PET in imaging bone metastases. Semin Nucl Med. 2009;39:396-407.
3. Ravizzini G, Turkbey B, Kurdziel K, Choyke PL. New horizons in prostate cancer imaging. Eur J Radiol. 2009;70:212-226.
4. Sodee DB, Sodee AE, Bakale G. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Semin Nucl Med. 2007;37:17-28. (Pubitemid 44854756)
5. Basu A, Goldenberg DM, Stein R. The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303. Int J Cancer. 1995;62:472-479.
6. Stein R, Basu A, Chen S, Shih LB, Goldenberg DM. Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody. Int J Cancer. 1993;55:938-946. (Pubitemid 24005338)
7. Stein R, Basu A, Goldenberg DM, Lloyd KO, Mattes MJ. Characterization of cluster 13: the epithelial/carcinoma antigen recognized by MAb RS7. Int J Cancer Suppl. 1994;8:98-102. (Pubitemid 24188968)
8. Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978;80:849-857. (Pubitemid 8305904)
9. Ruegg CL, Anderson-Berg WT, Brechbiel MW, Mirzadeh S, Gansow OA, Strand M. Improved in vivo stability and tumor targeting of bismuth-labeled antibody. Cancer Res. 1990;50:4221-4226. (Pubitemid 20225655)
10. Hnatowich DJ, Childs RL, Lanteigne D, Najafi A. The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J Immunol Methods. 1983;65:147-157. (Pubitemid 14203441)
11. 89Zr-labeled monoclonal antibodies. J Nucl Med. 2003;44:1271-1281.
12. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods. 1984;72:77-89. (Pubitemid 14091996)
13. Stein R, Govindan SV, Mattes MJ, et al. Improved iodine radiolabels for monoclonal antibody therapy. Cancer Res. 2003;63:111-118. (Pubitemid 36070428)
14. Hilgers J, Zotter S, Kenemans P. Polymorphic epithelial mucin and CA125-bearing glycoprotein in basic and applied carcinoma research. Cancer Rev. 1989;11-12:3-10. (Pubitemid 19206472)
15. Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer. Cancer Res. 1995;55(suppl):5857s-5863s.
16. 177Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab. J Nucl Med. 2005;46:1898-1906.
17. Reddy N, Lin Ong G, Behr TM, Sharkey RM, Goldenberg DM, Mattes MJ. Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations. Cancer Immunol Immunother. 1998;46:25-33. (Pubitemid 28133402)
18. Stein R, Chen S, Sharkey RM, Goldenberg DM. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting. Cancer Res. 1990;50:1330-1336. (Pubitemid 20084030)
19. Stein R, Chen S, Haim S, Goldenberg DM. Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft. Cancer. 1997;80(suppl):2636-2641. (Pubitemid 28009520)